Sensex, Nifty Set To Follow Global Peers Higher

RTTNews | 336 dias atrás
Sensex, Nifty Set To Follow Global Peers Higher

(RTTNews) - Indian shares look set to open on a firm note Monday, helped by firm global cues and continued FII buying.

Data showed foreign portfolio investors (FPIs) pumped in Rs. 43,838 crore in Indian equities in May, the highest level in nine months, with financials, telecom, automobile and construction sectors attracting big investments.

Focus shifts to the RBI policy meeting due this week, with most economists expecting policy rates to remain unchanged.

Asian markets extended a global rally this morning and gold eased on a firmer dollar while oil prices rose about 1 percent after Saudi Arabia decided to deepen its crude oil production cuts.

U.S. stocks posted strong gains on Friday as the latest jobs report delivered mixed signals and the passage of a debt-ceiling agreement helped avert concerns surrounding debt default.

The Dow rallied 2.1 percent, while the tech-heavy Nasdaq Composite surged 1.1 percent to reach over one-year high and the S&P 500 added 1.5 percent to set a new nine-month closing high.

Data showed non-farm employment soared by 339,000 jobs in May while economists had expected an increase of 190,000 jobs.

However, a rise in unemployment rate to a seven-month high of 3.7 percent and lower average hourly earnings helped keep alive hopes of Fed pausing rate hikes.

European stocks rose sharply on Friday amid easing U.S. debt worries.

The pan European STOXX 600 jumped 1.5 percent. The German DAX climbed 1.3 percent, France's CAC 40 jumped 1.9 percent and the U.K.'s FTSE 100 gained 1.6 percent.

read more
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 4 h 7 min atrás
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 4 h 11 min atrás
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 5 h 13 min atrás
Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone investor confidence improved for the seventh straight month in May to hit the highest level since February 2022 as both current situation and expectations rose in small but steady steps, a closely watched survey showed on Monday. The investor confidence index posted -3.6 in May, the behavioral research institute Sentix reported. The score was forecast to improve moderately to -4.8.
RTTNews | 5 h 22 min atrás
CAC 40 Gains On US Rate Cut Optimism

CAC 40 Gains On US Rate Cut Optimism

French stocks were slightly higher on Monday as optimism over interest rate cuts returned to the fore, following weaker-than-expected U.S. jobs data released on Friday. Also helping underpin sentiment, the latest HCOB PMI data produced by S&P Global showed that the French services economy began the second quarter of 2023 in expansion territory.
RTTNews | 7 h 14 min atrás